Skip to content

Akers biosciences股票预测

Akers biosciences股票预测

Akers Bio develops, manufactures, and supplies rapid, point-of-care screening and testing products designed to bring health-related information directly to the patient or clinician in a timely and cost-efficient manner. All of Akers Bio’s rapid, single-use tests are performed in vitro (outside the body) and are Akers Biosciences Inc. Akers Biosciences, Inc. engages in the development, manufacture, and supply of screening and testing products. Its products include clinical diagnostics and safety tests. Akers Biosciences Inc. all SEC filings breakout by MarketWatch. View the AKER U.S. Securities and Exchange Commission reporting information. Stock analysis for Akers Biosciences Inc (AKER:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. * AKERS BIOSCIENCES INC FILES FOR OFFER OF UP TO 793,437 SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDERS - SEC FILING Source text: (https://bit.ly/2ZstE7n) Further company coverage: BRIEF-Akers Akers Biosciences Inc. annual stock financials by MarketWatch. View the latest AKER financial statements, income statements and financial ratios.

亿帆医药(个股资料 操作策略 盘中直播 独家诊股). 亿帆医药事件点评:并购NovoTek,国际化进展再露峥嵘. 亿帆医药 002019. 研究机构:东兴证券 分析

Akers Biosciences, Inc. (the “Company”) (AKER), a developer of rapid health information technologies, today announced that Premas Biotech, its partner in the development of a vaccine candidate 亿帆医药(个股资料 操作策略 盘中直播 独家诊股). 亿帆医药事件点评:并购NovoTek,国际化进展再露峥嵘. 亿帆医药 002019. 研究机构:东兴证券 分析 BD Biosciences provides flow cytometers, reagents, tools, and a wide range of services to support the work of researchers and clinicians who understand disease and improve care.

Akers Biosciences Inc. Akers Biosciences, Inc. engages in the development, manufacture, and supply of screening and testing products. Its products include clinical diagnostics and safety tests.

Akers Biosciences Inc. all SEC filings breakout by MarketWatch. View the AKER U.S. Securities and Exchange Commission reporting information. Stock analysis for Akers Biosciences Inc (AKER:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. * AKERS BIOSCIENCES INC FILES FOR OFFER OF UP TO 793,437 SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDERS - SEC FILING Source text: (https://bit.ly/2ZstE7n) Further company coverage: BRIEF-Akers Akers Biosciences Inc. annual stock financials by MarketWatch. View the latest AKER financial statements, income statements and financial ratios. Akers Biosciences (AKER) reports earnings on 8/14/2020. The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings.

郑重声明:本网站所刊载的所有资料及图表仅供参考使用。投资者依据本网站提供的信息、资料及图表进行金融、证券等投资

Akers Bio develops, manufactures, and supplies rapid, point-of-care screening and testing products designed to bring health-related information directly to the patient or clinician in a timely and cost-efficient manner. All of Akers Bio’s rapid, single-use tests are performed in vitro (outside the body) and are

Akers Biosciences Inc. Akers Biosciences, Inc. engages in the development, manufacture, and supply of screening and testing products. Its products include clinical diagnostics and safety tests.

14 May 2020 Akers Biosciences Announces $4.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules. 14 May 2020 Akers Biosciences and Premas Biotech Announce Successful Completion of Vaccine Prototype & Obtained First Images of VLP Akers Bio develops, manufactures, and supplies rapid, point-of-care screening and testing products designed to bring health-related information directly to the patient or clinician in a timely and cost-efficient manner. All of Akers Bio’s rapid, single-use tests are performed in vitro (outside the body) and are Akers Biosciences Inc. Akers Biosciences, Inc. engages in the development, manufacture, and supply of screening and testing products. Its products include clinical diagnostics and safety tests. Akers Biosciences Inc. all SEC filings breakout by MarketWatch. View the AKER U.S. Securities and Exchange Commission reporting information. Stock analysis for Akers Biosciences Inc (AKER:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. * AKERS BIOSCIENCES INC FILES FOR OFFER OF UP TO 793,437 SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDERS - SEC FILING Source text: (https://bit.ly/2ZstE7n) Further company coverage: BRIEF-Akers

Apex Business WordPress Theme | Designed by Crafthemes